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FIRST CLINICAL CASE REPORTFacklamia hominis scapula abscess, Marseille, FranceC. Abat, V. Garcia and J.-M. Rolain
Aix-Marseille Université, URMITE UM 63 CNRS 7278 IRD 198 INSERM U1905, Méditerranée Infection, Facultés de Médecine et de Pharmacie,
Marseille, FranceAbstractFacklamia hominis is a Gram-positive bacterium that was ﬁrst isolated from various human samples, excluding abscesses of the scapula.
We here report the ﬁrst scapular abscess infection due to F. hominis, found in Marseille, France. We also reviewed all cases published in
the literature.
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E-mail: jean-marc.rolain@univ-amu.frFacklamia hominis is a catalase-negative facultative anaerobic and
Gram-positive bacterium that was initially isolated from urine,
vagina, blood and abscesses in humans [1]. The bacteria was
then recovered from placentas [2], mitral valves [3,4], and joints
[5]. Here we report the ﬁrst human case of scapular abscess
due to F. hominis, found in Marseille, France.
A 40-year-old woman was admitted to the emergency
department at Casamance Hospital, Marseille, for persistent
pain in an abscess located on the left scapula. For 15 years, the
patient had an indurated mass on her left scapula after surgical
evacuation of a worm. The ﬁrst suppuration of this mass was
reported 3 years ago. One week before hospitalization, she
consulted her doctor for increasing pain and the formation of
an abscess on her left scapula. Because the patient was apyretic,
the doctor decided to treat her with pristinamycine. Upon
admission on 29 January 2015, she was apyretic. She had no
cervical adenopathy, and her white blood cell count was normal
(4.18 × 109/L). Surgical drainage of the infected abscess wasNew Microbes and New Infections © 2015 The Authors. Published by El
This is an open access artiperformed. During surgery, a subcutaneous sample was
recovered. After culture, F. hominis was repeatedly identiﬁed
from several colonies tested by matrix-assisted laser desorp-
tion/ionization time-of-ﬂight mass spectrometry (MALDI-TOF),
with a score of 1.77. The bacterium was susceptible to ceftri-
axone, gentamicin, erythromycin, rifampicin, doxycycline and
vancomycin and resistant to clindamycin. At last contact, the
patient was still being treated with pristinamycin.
F. hominis has been isolated exclusively from human samples
(Table 1). Indeed, 67% (8/12) of all the F. hominis cases pub-
lished worldwide were isolated from female human subjects
(Table 1). The fact that this bacterial species has rarely been
isolated from humans can be explained by the ineffectiveness
of traditional microbiologic tests to accurately identify F.
hominis. Previous studies have highlighted this problem, arguing
that traditional microbiologic methods for microbial identiﬁ-
cation incorrectly identiﬁed Facklamia spp. strains as respon-
sible for endocarditis, whereas 16S rRNA PCR ﬁnally identiﬁed
Enterococcus faecalis [4]. In the present study, the bacterial
species was identiﬁed and conﬁrmed several times using
MALDI-TOF. Over the years, this strategy has considerably
increased our capacity to detect rare bacterial species from
clinical samples [6]. Table 1 summarizes the characteristics of
the cases of F. hominis infection or carriage reported in the
literature. In our case, and because the patient did not haveNew Microbe and New Infect 2016; 9: 13–14
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TABLE 1. Worldwide human infections with Facklamia hominis
No. of
patients
(country) Sex Positive sample Identiﬁcation method Antibiotic therapy provided Result Reference
6 (5 Sweden, 1 France) 4 F, 2 NA 1 urine, 3 vagina,
1 blood, 1 abscess
Characterization by API
Rapid ID32 and API ZYM
NA NA [1]
2 (United Kingdom) 2 F Blood, placental tissue,
gastric aspirate
NA Co-amoxiclav, metronidazole, ampicillin,
teicoplanin, gentamycin, cefotaxime
Discharged cured [2]
1 (India) M Blood Vitek 2 system Penicillin, gentamicin, ceftriaxone Cured [3]
1 (Spain) F Sample from joint
pseudo-capsule
Vitek 2 system 16S rRNA
PCR
Vancomycin gentamicin, ceftriaxone,
amoxicillin
Cured [5]
1 (United Kingdom) NA Blood NA Amoxicillin + clavulanic acid, gentamicin, vancomycin Died [4]
1 (France) F Abscess MALDI-TOF Pristinamycine Under treatment This study
NA, data not available; MALDI-TOF, matrix-assisted laser desorption/ionization time-of-ﬂight mass spectrometry.
14 New Microbes and New Infections, Volume 9 Number C, January 2016 NMNIany underlying conditions, we speculate that the infection was
facilitated by repeated contact of the surgical site with
contaminated surfaces such as hands. All together, our ob-
servations emphasize that F. hominis is an emerging pathogen
that may be responsible for opportunistic infections in
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